Dashboard
Manage Tickers

SYKSTRYKER CORP

NYSE stryker.com


$ 372.01 $ 1.71 (0.46 %)    

Monday, 16-Sep-2024 15:59:56 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 473.14 $ -2.10 (-0.44 %)
DIA $ 417.33 $ 2.44 (0.59 %)
SPY $ 562.48 $ 0.83 (0.15 %)
TLT $ 101.29 $ 0.92 (0.92 %)
GLD $ 238.61 $ -0.02 (-0.01 %)
$ 371.96
$ 373.88
$ 371.88 x 100
$ 380.03 x 100
$ 369.99 - $ 374.13
$ 248.16 - $ 374.63
910,077
na
141.74B
$ 1.19
$ 41.11
TBD
na
na ($ 0.01)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 07-31-2024 06-30-2024 10-Q
2 05-01-2024 03-31-2024 10-Q
3 02-14-2024 12-31-2023 10-K
4 11-03-2023 09-30-2023 10-Q
5 08-04-2023 06-30-2023 10-Q
6 05-02-2023 03-31-2023 10-Q
7 02-10-2023 12-31-2022 10-K
8 11-01-2022 09-30-2022 10-Q
9 07-27-2022 06-30-2022 10-Q
10 04-29-2022 03-31-2022 10-Q
11 02-11-2022 12-31-2021 10-K
12 10-29-2021 09-30-2021 10-Q
13 07-28-2021 06-30-2021 10-Q
14 04-28-2021 03-31-2021 10-Q
15 02-11-2021 12-31-2020 10-K
16 10-30-2020 09-30-2020 10-Q
17 07-31-2020 06-30-2020 10-Q
18 05-01-2020 03-31-2020 10-Q
19 02-06-2020 12-31-2019 10-K
20 10-30-2019 09-30-2019 10-Q
21 07-26-2019 06-30-2019 10-Q
22 04-24-2019 03-31-2019 10-Q
23 02-07-2019 12-31-2018 10-K
24 10-26-2018 09-30-2018 10-Q
25 07-25-2018 06-30-2018 10-Q
26 04-27-2018 03-31-2018 10-Q
27 02-08-2018 12-31-2017 10-K
28 10-27-2017 09-30-2017 10-Q
29 07-28-2017 06-30-2017 10-Q
30 04-27-2017 03-31-2017 10-Q
31 02-09-2017 12-31-2016 10-K
32 10-28-2016 09-30-2016 10-Q
33 07-22-2016 06-30-2016 10-Q
34 04-22-2016 03-31-2016 10-Q
35 02-11-2016 12-31-2015 10-K
36 10-23-2015 09-30-2015 10-Q
37 07-29-2015 06-30-2015 10-Q
38 04-30-2015 03-31-2015 10-Q
39 02-12-2015 12-31-2014 10-K
40 10-23-2014 09-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

stryker-unveils-new-foot--ankle-solutions-with-truss-implants-details
Stryker Unveils New Foot & Ankle Solutions...
09/11/2024 17:43:06

Stryker Corporation announced new Foot & Ankle products from 4WEB Medical, with analysts maintaining positive ratings.

stryker-expands-foot--ankle-portfolio-with-the-osteotomy-truss-system-and-ankle-truss-system-recently-acquired-from-4web-medical-will-feature-both-the-ots-and-ats-the-newly-acquired-artelon-portfolio-and-other-products-at-the-aofas-annual-meeting
Stryker Expands Foot & Ankle Portfolio Wit...
09/11/2024 12:27:32

The company to feature new products at American Orthopaedic Foot & Ankle Society Annual MeetingStryker (NYSE:SYK), a global...

heres-how-much-you-would-have-made-owning-stryker-stock-in-the-last-15-years
Here's How Much You Would Have Made Owning...
09/10/2024 19:30:28

piper-sandler-maintains-overweight-on-stryker-maintains-380-price-target
Piper Sandler Maintains Overweight on Stry...
09/10/2024 14:33:08

Piper Sandler analyst Matt O'Brien maintains Stryker (NYSE:SYK) with a Overweight and maintains $380 price target.

wolfe-research-initiates-coverage-on-stryker-with-outperform-rating-announces-price-target-of-405
Wolfe Research Initiates Coverage On Stryk...
09/10/2024 10:10:41

Wolfe Research analyst Mike Polark initiates coverage on Stryker (NYSE:SYK) with a Outperform rating and announces Price Tar...

deep-dive-into-stryker-stock-analyst-perspectives-11-ratings
Deep Dive Into Stryker Stock: Analyst Pers...
08/28/2024 17:00:16

btig-maintains-buy-on-stryker-raises-price-target-to-374
BTIG Maintains Buy on Stryker, Raises Pric...
08/28/2024 16:45:48

BTIG analyst Ryan Zimmerman maintains Stryker (NYSE:SYK) with a Buy and raises the price target from $360 to $374.

stryker-signs-definitive-agreement-to-acquire-vertos-medical-no-terms-disclosed
Stryker Signs Definitive Agreement To Acqu...
08/22/2024 12:01:24

Stryker (NYSE:SYK), a global leader in medical technologies, announced today a definitive agreement to acquire Vertos Medical I...

100-invested-in-this-stock-10-years-ago-would-be-worth-400-today
$100 Invested In This Stock 10 Years Ago W...
08/21/2024 15:30:18

how-is-the-market-feeling-about-stryker
How Is The Market Feeling About Stryker?
08/15/2024 17:45:17

100-invested-in-stryker-15-years-ago-would-be-worth-this-much-today
$100 Invested In Stryker 15 Years Ago Woul...
08/09/2024 15:00:32

stryker-launches-pangea-plating-system-to-enhance-trauma-care-with-reliable-user-friendly-solutions-receives-fda-clearance-in-late-2023
Stryker Launches Pangea Plating System To ...
08/06/2024 12:21:43

barclays-maintains-overweight-on-stryker-raises-price-target-to-402
Barclays Maintains Overweight on Stryker, ...
08/01/2024 16:44:43

Barclays analyst Matt Miksic maintains Stryker (NYSE:SYK) with a Overweight and raises the price target from $374 to $402.

truist-securities-maintains-hold-on-stryker-lowers-price-target-to-345
Truist Securities Maintains Hold on Stryke...
08/01/2024 13:39:45

Truist Securities analyst Richard Newitter maintains Stryker (NYSE:SYK) with a Hold and lowers the price target from $364 to...

needham-maintains-buy-on-stryker-raises-price-target-to-393
Needham Maintains Buy on Stryker, Raises P...
08/01/2024 10:14:44

Needham analyst Mike Matson maintains Stryker (NYSE:SYK) with a Buy and raises the price target from $392 to $393.

btig-maintains-buy-on-stryker-lowers-price-target-to-360
BTIG Maintains Buy on Stryker, Lowers Pric...
07/31/2024 18:48:32

BTIG analyst Ryan Zimmerman maintains Stryker (NYSE:SYK) with a Buy and lowers the price target from $372 to $360.

what-8-analyst-ratings-have-to-say-about-stryker
What 8 Analyst Ratings Have To Say About S...
07/31/2024 18:00:59

stifel-maintains-buy-on-stryker-lowers-price-target-to-365
Stifel Maintains Buy on Stryker, Lowers Pr...
07/31/2024 15:52:13

Stifel analyst Rick Wise maintains Stryker (NYSE:SYK) with a Buy and lowers the price target from $375 to $365.

ubs-maintains-neutral-on-stryker-raises-price-target-to-366
UBS Maintains Neutral on Stryker, Raises P...
07/31/2024 15:37:42

UBS analyst Danielle Antalffy maintains Stryker (NYSE:SYK) with a Neutral and raises the price target from $351 to $366.

rbc-capital-reiterates-outperform-on-stryker-maintains-386-price-target
RBC Capital Reiterates Outperform on Stryk...
07/31/2024 15:32:31

RBC Capital analyst Shagun Singh reiterates Stryker (NYSE:SYK) with a Outperform and maintains $386 price target.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION